Shares of Sun Pharma tanked 10 percent intraday on Monday as its March quarter results missed street expectations. Its fourth quarter consolidated... ...http://www.moneycontrol.com/news/buzzing-stocks/sun-pharma-tanks-10-whyanalysts-bullish-post-q4_1395804.html
/PRNewswire/ --Novartis will highlight the strength of its expanded oncology portfolio in 21 medicines and 11 investigational compounds across more... ...http://in.advfn.com/p.php?pid=nmona&article=67036355
/PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/htr9zk/cancer_targeted) has announced the addition of the"... ...http://in.advfn.com/p.php?pid=nmona&article=66929373
Tobacco use smoking and chewing is the single most important factor which causes cancer. When the World Health Organisation added 16 new... ...http://indianexpress.com/article/lifestyle/health/cancer-treatment-aint-just-for-the-rich/
Express Pharma presents reactions to the recently released 2015 USTR Special 301 Report OPPI welcomes the continued focus on strengthening IPR... ...http://www.financialexpress.com/article/pharma/latest-updates/2015-ustr-special-301-report-reactions-and-the-way-forward/71618/
For Buying Imatinib & Gleevec Online...